Last reviewed · How we verify

NCT04209101: NC

Medical Students and Psychoactive Substances Use

Completed Last updated 23 December 2019
What this trial tests

trial in Psychoactive Substances Consumption in 942 participants. Completed in 30 June 2017.

Timeline
1 January 2017
Primary endpoint
1 June 2017
30 June 2017

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusCompleted
Study typeOBSERVATIONAL
Enrollment942
Start date1 January 2017
Primary completion1 June 2017
Estimated completion30 June 2017
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Psychoactive Substances Consumption. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Medical students are heavy users of psychoactive substances, and even if levels of use vary depending on the universities, the average levels are higher than most other students. In France, however, the use of licit or illicit substance has not been precisely described in medical students. The aim of this study was therefore to define the different modes of consumption of medical students. Methods: This study was a cross-sectional survey in medical students from the University of Montpellier, and the investigators performed a cluster analysis of data. Both medical students and residents were included. Socio-demographic, medico-psychological and addictological data were collected.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04209101.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing